Skip to main content
SpringerLink
Log in

Transport for abciximab facilitated primary angioplasty versus on-site thrombolysis with a liberal rescue policy: the randomised Holland Infarction Study (HIS)

  • Clinical Trials
  • Published:
Journal of Thrombosis and Thrombolysis Aims and scope Submit manuscript

Abstract

Aims: As of to date, the only large transportation trial comparing on-site fibrin-specific thrombolysis with transfer for primary angioplasty in patients presenting in a referral centre is the DANAMI-2 trial, with only 3% rescue angioplasty. The Holland Infarction Study (HIS) compared abciximab facilitated primary angioplasty (FP) with on-site fibrin-specific thrombolytic therapy (TT) with a liberal protocol-driven rescue angioplasty (transport to intervention centre in case < 50% ST resolution at 60 min).

Methods and Results: Patients in a referral centre without shock and < 4.5 h of chest pain presenting with ST-elevation having ≥ 12 mm ST-segment shift were randomised to either strategy. Of the originally planned 900 patients only 48 were included due to suspension of financial funding. Death, recurrent MI and stroke at one year was 8% for the FP-group and 22% for the TT-group (p = 0.2). Two hours after randomisation the rates of complete ST-segment resolution (≥70%) were 52% and 35%, respectively (p = 0.2).

Conclusion: This prematurely discontinued randomised transportation trial shows favorable trends with respect to long-term clinical outcome and early ST-resolution for abciximab facilitated primary angioplasty. In view of the real world delays associated with interhospital transport for primary angioplasty, treatment strategies focusing on early fibrin-specific lysis with a liberal selective rescue policy are warranted.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Weaver WD, Simes RJ, Betriu A, et al. (1997) Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction. JAMA 278:2093–2098

    Article  PubMed  CAS  Google Scholar 

  2. Dieker H, Brouwer MA, van Horssen EV, et al. (2004) Fibrinolysis and primary PCI for ST-elevation myocardial infarction: call for a more refined perspective. Neth Heart J 12:343–346

    Google Scholar 

  3. Andersen HR, Nielsen TT, Rasmussen K, et al. (2003) A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction. N Engl J Med 349:733–742

    Article  PubMed  Google Scholar 

  4. Antoniucci D, Migliorini A, Parodi G, et al. (2004) Abciximab-supported infarct artery stent implantation for acute myocardial infarction and long-term survival. A prospective, multicentre, randomised trial comparing infarct artery stenting plus abciximab with stenting alone. Circulation 109:1704–1706

    Article  PubMed  CAS  Google Scholar 

  5. Montalescot G, Borentain M, Payot L, et al. (2004) Early vs late administration of glycoprotein IIb/IIIa inhibitors in primary coronary intervention of acute ST-segment elevation myocardial infarction. A meta-analysis. JAMA 292:362–366

    Article  PubMed  CAS  Google Scholar 

  6. Stone GW, Cox D, Garcia E, et al. (2001) Normal flow (TIMI-3) before mechanical reperfusion therapy is an independent determinant of survival in acute myocardial infarction. Analysis from the primary angioplasty in myocardial infarction trials. Circulation 104:636–641

    PubMed  CAS  Google Scholar 

  7. Ellis SG, Da Silva ER, Spaulding CM, et al. (2000) Review of immediate angioplasty after fibrinolytic therapy for acute myocardial infarction: insights from the RESCUE I, RESCUE II, and other contemporary clinical experiences. Am Heart J 139:1046–1053

    Google Scholar 

  8. Cannon CP, McCabe CH, Wilcox RG, et al. (2000) Oral glycoprotein IIb/IIIa inhibition with orbofiban in patients with unstable coronary syndromes (OPUS-TIMI 16) trial. Circulation 102:149–156

    PubMed  CAS  Google Scholar 

  9. Schröder R, Zeymer U, Wegschreider K, et al. (1999) Comparison of the predictive value of ST segment elevation resolution at 90 and 180 min after start of streptokinase in acute myocardial infarction: a substudy of the Hirudin for Improvement of Thrombolysis (HIT)-4. Eur Heart J 20:1563–1571

    Article  PubMed  Google Scholar 

  10. Vermeer F, Oude Ophuis AJM, vd Berg EJ, et al. (1999) Prospective randomised comparison between thrombolysis, rescue PTCA, and primary PTCA in patients with extensive myocardial infarction admitted to a hospital without PTCA facilities: a safety and feasibility study. Heart 82:426–431

    Google Scholar 

  11. Widimsky P, Groch L, Zelizko M, et al. (2001) Multicentre randomized trial comparing transport to primary angioplasty vs immediate thrombolysis vs combined strategy for patients with acute myocardial infarction presenting to a community hospital without a catheterisation laboratory. The PRAGUE Study. Eur Heart J 21:823–831

    Article  Google Scholar 

  12. Widimsky P, Budesinsky T, Vorac D, et al. (2003) Long distance transport for primary angioplasty vs immediate thrombolysis in acute myocardial infarction. Final results of the randomized national multicentre trial-PRAGUE-2. Eur Heart J 24:94–104

    Article  PubMed  CAS  Google Scholar 

  13. Grines CL, Westerhausen DR, Grines LL, et al. (2002)A randomized trial of transfer for primary angioplasty versus on-site thrombolysis in patients with high-risk myocardial infarction. The air primary angioplasty in myocardial infarction study. J Am Coll Cardiol 39:1713–1719

    Article  PubMed  Google Scholar 

  14. de Lemos JA, Braunwald E. ST (2001) segment resolution as a tool for assessing the efficacy of reperfusion therapy. J Am Coll Cardiol 38:1283–1294

    Article  PubMed  CAS  Google Scholar 

  15. Van’t Hof AW, Liem A, de Boer M, et al. (1997) Clinical value of 12-lead electrocardiogram after successful reperfusion therapy for acute myocardial infarction. Lancet 350:615–619

    Article  Google Scholar 

  16. Keeley EC, Boura JA, Grines CL (2003) Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet 361:13–20

    Article  PubMed  Google Scholar 

  17. GUSTO Investigators (1993) An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 329:673–682

    Article  Google Scholar 

  18. Bär F, Vainer J, Stevenhagen J, et al. (2000) Ten-year experience with early angioplasty in 759 patients with acute myocardial infarction. J Am Coll Cardiol 36:51–58

    Article  PubMed  Google Scholar 

  19. Nallamothu BK, Bates ER, Herrin J, et al. (2005) Times to treatment in transfer patients undergoing primary percutaneous coronary intervention in the United States. National Registry of Myocardial Infarction (NRMI)-3/4 analysis. Circulation 111:761–767

    Article  PubMed  Google Scholar 

  20. Morrison LJ, Verbeek PR, McDonald AC, et al. (2000) Mortality and prehospital thrombolysis for acute myocardial infarction: A meta-analysis. JAMA 283:2686–2692

    Article  PubMed  CAS  Google Scholar 

  21. Terkelsen CJ, Lassen JF, Norgaard BL, et al. (2005) Reduction of treatment delay in patients with ST-elevation myocardial infarction: impact of pre-hospital diagnosis and direct referral to primary percutaneous intervention. Eur Heart J 26:770–777

    Article  PubMed  Google Scholar 

  22. Bonnefoy E, Lapostolle F, Leizorovicz A, et al. (2002) Primary angioplasty versus prehospital fibrinolysis in acute myocardial infarction: a randomised study. Lancet 360:825–829

    Article  PubMed  Google Scholar 

  23. Gershlick AH, Stephens-Lloyd A, Hughes S, et al. (2005) Rescue angioplasty after failed thrombolytic therapy for acute myocardial infarction. N Engl J Med 353:2758–2768

    Article  PubMed  CAS  Google Scholar 

  24. Assessment of the Safety and Efficacy of New Treatment Strategy with Percutaneous Coronary Intervention (ASSENT-4 PCI) Investigators. (2006) Primary versus tenecteplase-faciltated percutaneous coronary intervention in patients with ST-segment elevation acute myocardial infarction (ASSENT-4 PCI): Randomised trial. Lancet 367:569–578.

    Google Scholar 

  25. Ross AM, Coyne KS, Reiner JS, et al. (1999) A randomized trial comparing primary angioplasty with a strategy of short-acting thrombolysis and immediate planned rescue angioplasty in acute myocardial infarction: the PACT trial. J Am Coll Cardiol 34:1954–1962

    Article  PubMed  CAS  Google Scholar 

  26. The Assessment of the Safety and Efficacy of a new Thrombolytic regimen (ASSENT)-3 Investigators. Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: the ASSENT-3 randomised trial in acute myocardial infarction. Lancet 2001;358:605–613

    Google Scholar 

  27. Wallentin L, Goldstein P, Armstrong PW, et al. (2003) Efficacy and safety of tenecteplase in combination with the low-molecular weight heparin enoxaparin or unfractionated heparin in the prehospital setting. The assessment of the safety anf efficacy of a new thrombolytic regimen (ASSENT)-3 PLUS randomized trial in acute myocardial infarction. Circulation 108:135–142

    Article  PubMed  CAS  Google Scholar 

  28. Antman EM, Morrow DA, McCAbe CH, et al. (2005) Enoxaparin versus unfractionated heparin as antithrombin therapy in patients receiving fibrinolysis for ST-elevation myocardial infarction: Design and rationale for the Enoxaparin and Thrombolysis reperfusion for acute myocardial infarction treatment-thrombolysis in myocardial infarction study 25 (ExTRACT-TIMI 25). Am Heart J 149:217–224

    Article  PubMed  CAS  Google Scholar 

  29. Kereiakes DJ, Grines C, Fry E, et al. Enoxaparin and abciximab adjunctive pharmacotherapy during percutaneous coronary intervention. J Invasive Cardiol 13:272–278

  30. Sabatine MS, Cannon CP, Gibson CM, et al. (2005) Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation. New Engl J Med 352:1179–1189

    Article  PubMed  CAS  Google Scholar 

  31. COMMIT collaborative group. (2005) Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: Randomised placebo-controlled trial. Lancet 366:1607–1621

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Cardiology, Radboud University Nijmegen Medical Centre, P.O. Box 9101, 6500 HB, Nijmegen, The Netherlands

    Hendrik-Jan Dieker, Marc A. Brouwer, Wim R. M. Aengevaeren & Freek W. A. Verheugt

  2. Department of Cardiology, University Medical Centre Groningen, Groningen

    Elvira V. van Horssen & Ad J. van Boven

  3. Department of Cardiology, Isalaklinieken Zwolle, The Netherlands

    Arnoud W. J. van’t Hof

  4. Department of Cardiology, University Hospital Maastricht, Maastricht

    Ferry M. R. J. Hersbach & Frits W. H. M. Bär

Authors
  1. Hendrik-Jan Dieker
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Elvira V. van Horssen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ferry M. R. J. Hersbach
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Marc A. Brouwer
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ad J. van Boven
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Arnoud W. J. van’t Hof
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Wim R. M. Aengevaeren
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Freek W. A. Verheugt
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Frits W. H. M. Bär
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hendrik-Jan Dieker.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dieker, HJ., van Horssen, E.V., Hersbach, F.M.R.J. et al. Transport for abciximab facilitated primary angioplasty versus on-site thrombolysis with a liberal rescue policy: the randomised Holland Infarction Study (HIS). J Thromb Thrombolysis 22, 39–45 (2006). https://doi.org/10.1007/s11239-006-7731-6

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11239-006-7731-6

Keywords

Search

Navigation